engleski

Efficacy and tolerability of standard doses of ranitidine, omeprasole and pantoprasole in patients with gastro-oesophageal reflux disease (GORD).

GERD is a common condition affecting 7% of the population on a daily basis.One of the primary aims of therapy for GORD is to reduce the acidity of refluxed material to which the oesophageal mucosa is exposed. Conclusions: 1.Pharmacologically, acid suppressing therapy with standard doses of PPI has markedly improved the outcome of GORD, 2. Within PPI classes, pantoprasole has much better results (fewer GORD symptoms, fewer side-effects, better E and HA improvement), 3.Pantoprasole is highly effective and well tolerated in the treatment of GORD.

GORD; proton pump inhibitors

nije evidentirano